Mendelian randomization for cardiovascular diseases: principles and applications

SC Larsson, AS Butterworth… - European heart journal, 2023 - academic.oup.com
Large-scale genome-wide association studies conducted over the last decade have
uncovered numerous genetic variants associated with cardiometabolic traits and risk factors …

Exercise, exerkines, and cardiometabolic health: from individual players to a team sport

JM Robbins, RE Gerszten - The Journal of clinical …, 2023 - Am Soc Clin Investig
Exercise confers numerous salutary effects that extend beyond individual organ systems to
provide systemic health benefits. Here, we discuss the role of exercise in cardiovascular …

The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods

B Zdrazil, E Felix, F Hunter, EJ Manners… - Nucleic acids …, 2024 - academic.oup.com
Abstract ChEMBL (https://www. ebi. ac. uk/chembl/) is a manually curated, high-quality, large-
scale, open, FAIR and Global Core Biodata Resource of bioactive molecules with drug-like …

Pan-UK Biobank GWAS improves discovery, analysis of genetic architecture, and resolution into ancestry-enriched effects

KJ Karczewski, R Gupta, M Kanai, W Lu, K Tsuo… - MedRxiv, 2024 - medrxiv.org
Large biobanks, such as the UK Biobank (UKB), enable massive phenome by genome-wide
association studies that elucidate genetic etiology of complex traits. However, individuals …

Biobanking with genetics shapes precision medicine and global health

CS Gallagher, GS Ginsburg, A Musick - Nature Reviews Genetics, 2024 - nature.com
Precision medicine provides patients with access to personally tailored treatments based on
individual-level data. However, developing personalized therapies requires analyses with …

Pathophysiological insights into HFpEF from studies of human cardiac tissue

AU Fayyaz, M Eltony, LJ Prokop, KE Koepp… - Nature Reviews …, 2024 - nature.com
Heart failure with preserved ejection fraction (HFpEF) is a major, worldwide health-care
problem. Few therapies for HFpEF exist because the pathophysiology of this condition is …

Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillation

M van Vugt, C Finan, S Chopade, R Providencia… - Genome Medicine, 2024 - Springer
Background Altered metabolism plays a role in the pathophysiology of cardiac diseases,
such as atrial fibrillation (AF) and heart failure (HF). We aimed to identify novel plasma …

Clinical-transcriptional prioritization of the circulating proteome in human heart failure

AS Perry, K Amancherla, X Huang, ML Lance… - Cell Reports …, 2024 - cell.com
Given expanding studies in epidemiology and disease-oriented human studies offering
hundreds of associations between the human" ome" and disease, prioritizing molecules …

[HTML][HTML] Sex-stratified genome-wide association and transcriptome-wide Mendelian randomization studies reveal drug targets of heart failure

Q Yang, Q Yang, X Wu, R Zheng, H Lin, S Wang… - Cell Reports …, 2024 - cell.com
The prevalence of heart failure (HF) subtypes, which are classified by left ventricular ejection
fraction (LVEF), demonstrate significant sex differences. Here, we perform sex-stratified …

Identifying prothrombin and bone sialoprotein as potential drug targets for idiopathic pulmonary fibrosis

Y Chen, S Cao, S Shao, Z Tong - BMC Pulmonary Medicine, 2024 - Springer
Abstract Background Idiopathic Pulmonary Fibrosis (IPF) is a fatal disease with scarce
therapeutic alternatives, which imposes a significant economic burden on society. The …